MANGONI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 6.375
EU - Europa 4.287
AS - Asia 1.016
AF - Africa 30
SA - Sud America 3
OC - Oceania 2
Totale 11.713
Nazione #
US - Stati Uniti d'America 6.362
RU - Federazione Russa 1.539
PL - Polonia 1.033
IT - Italia 563
IE - Irlanda 427
SE - Svezia 384
SG - Singapore 262
HK - Hong Kong 261
CN - Cina 251
FI - Finlandia 86
DE - Germania 85
JO - Giordania 77
IN - India 75
GB - Regno Unito 41
UA - Ucraina 40
KR - Corea 36
TR - Turchia 26
ES - Italia 25
CI - Costa d'Avorio 24
VN - Vietnam 18
CH - Svizzera 14
FR - Francia 14
BE - Belgio 11
CA - Canada 11
CZ - Repubblica Ceca 7
NL - Olanda 7
AT - Austria 5
BG - Bulgaria 5
JP - Giappone 4
BR - Brasile 3
DZ - Algeria 3
ID - Indonesia 3
AU - Australia 2
PH - Filippine 2
EG - Egitto 1
GL - Groenlandia 1
LK - Sri Lanka 1
LT - Lituania 1
NG - Nigeria 1
PR - Porto Rico 1
SC - Seychelles 1
Totale 11.713
Città #
Santa Clara 1.129
Warsaw 1.030
Fairfield 815
Chandler 502
Ashburn 443
Dublin 427
Cambridge 352
Seattle 352
Woodbridge 338
Houston 302
Wilmington 253
Singapore 206
Florence 181
Hong Kong 164
Lawrence 149
Altamura 135
Ann Arbor 131
Princeton 119
Beijing 112
Jacksonville 86
Buffalo 76
Boston 66
Dearborn 65
Mumbai 56
Medford 55
San Diego 51
Shanghai 49
Moscow 48
Boardman 45
New York 30
Falls Church 26
Kent 26
Munich 25
Abidjan 24
Izmir 24
Norwalk 21
Seoul 17
Hillsboro 16
Los Angeles 16
Barcelona 14
Bern 13
Milan 13
Pune 13
Redwood City 12
Rome 12
Brussels 11
Dong Ket 10
Andover 9
West Jordan 9
Helsinki 8
A Coruña 7
Nanjing 7
Phoenix 7
Toronto 7
Yubileyny 7
Brno 6
Cagliari 6
London 6
Bologna 5
Guangzhou 5
Pistoia 5
Sofia 5
Kunming 4
Paris 4
Prato 4
Redmond 4
Bandung 3
Blida 3
Castelliri 3
Chongqing 3
Fontebuona 3
Garden City 3
Genoa 3
Jiaxing 3
Old Bridge 3
Palermo 3
Pontedera 3
Radomsko 3
San Mateo 3
Shenzhen 3
Xi'an 3
Azzano Decimo 2
Bergamo 2
Bojano 2
Bremen 2
Castelfiorentino 2
Cerveteri 2
Delhi 2
Falkenstein 2
Ferrara 2
Fiesole 2
Figline Valdarno 2
Frankfurt am Main 2
Frascati 2
Gambassi 2
Ghaziabad 2
Kofu 2
Laurel 2
Leganés 2
Lodi 2
Totale 8.258
Nome #
Stereotactic body radiotherapy for cardiac and paracardiac metastases: University of Florence experience. 245
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 243
Role of chemotherapy in nasopharyngeal carcinoma 243
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance. 235
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 230
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy. 203
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy inmetastatic breast cancer: a retrospective analysis. 199
PHARMACOLOGICAL MODULATION OF NORMAL TISSUES RESPONSETO RADIATION-INDUCED DAMAGES 193
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. 160
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 148
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. 144
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 142
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 141
Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery. 139
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 139
A new standardized data collection system for interdisciplinary thyroid cancer management: Thyroid COBRA 134
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 133
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 132
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 130
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 128
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 128
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 126
Breast cancer in the elderly: treatment of 1500 patients. 124
Use of tamoxifen in pT1a-pT1b, pN0 breast cancer. 124
Adjuvant trastuzumab in breast cancer: experience from the University of Florence. 123
Radiotherapy in the age of cancer immunology: Current concepts and future developments 121
Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen. 120
Post-ABVD/pre-radiotherapy 18F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: A retrospective analysis on 165 patients 120
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 119
PV-0512: Accelerated partial breast irradiation for Luminal-A breast cancer: analysis from a phase 3 trial 119
76P THE IMPACT OF A BREATHING-CONTROL SYSTEM ON TARGET MARGINS AND NORMAL TISSUE SPARING IN THE TREATMENT OF LUNG CANCER: ANALYSIS OF 12 CASES AT RADIOTHERAPY UNIT OF FLORENCE UNIVERSITY 117
Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: single-institution experience and review of published literature 117
135 An heparan-mimetic protects mice from radiation-induced mucositis 116
Doxorubicin and cyclophosphamideversus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvantchemotherapy in breast cancer. 115
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 114
Cancer stem cells: biology and potential therapeutic applications 113
Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases. 113
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 113
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 112
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 109
Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions 109
Accelerated Partial Breast Irradiation with IMRT: New Technical Approach and Interim Analysis of Acute Toxicity in a Phase III Randomized Clinical Trial. 108
Radioterapia 107
Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a singleinstitution experience. 107
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 107
Radiomic and dosiomic profiling of paediatric medulloblastoma tumours treated with intensity modulated radiation therapy 106
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 105
The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis 105
Rosiglitazone(RGZ) Attenuates Pulmonary Fibrosis and Radiation-induced Intestinal Damage 104
Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin 104
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 104
From a waiting list to a priority list: a computerized model for an easy-to-manage and automatically updated priority list in the booking of patients waiting for radiotherapy. 102
Association between genetic polymorphisms in the XRCC1,XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivityin breast cancer patients. 102
Cutaneous and cardiac toxicity of concurrent trastuzumab and adjuvant breast radiotherapy: a single institution series. 101
Radiotherapy Timing in 4,820 patients with Breast Cancer: University of Florence Experience. 100
Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University. 99
Stem cell tracking: toward clinical application in oncology? 98
Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclines. 98
Temporomandibular joint (TMJ): recent techniques of visualization 97
Impact of sentinel node tumor burden on outcome of invasive breast cancer patients. 97
Single nucleotide polymorphisms at 241 codon of XRCC3 gene is associated with acute skin reactions after radiotherapy for breast cancer 96
Organs at risk in the brain and their dose-constraints in adults and in children: A radiation oncologist's guide for delineation in everyday practice. 96
Magnetic resonance imaging of stem cell application in oncology 95
Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients. 95
Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature. 94
Dosimetric Predictors of Acute and Chronic Alopecia in Primary Brain Cancer Patients Treated With Volumetric Modulated Arc Therapy 94
In vivo evaluation of the lung scissures anatomy using 16 rows MDTC MPR (multiplanar recontruction) 92
Elementi di Radioterapia Oncologica 91
Biomarkers in wound drainage fluids of head and neck squamous cell carcinoma patients receiving neck dissection: A pilot study 91
Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection. 88
Limited-stage small-cell lung cancer treated with early chemo-radiotherapy: the impact of effective chemotherapy. 87
Antitumor effect and interaction with ionizing radiation of PPAR_GAMMA on adrenocortical carcinoma 83
Protective Effect of Leuprorelin on Radiation-induced Intestinal Toxicity 82
Stimulated expression of CXCL12 in adrenocortical carcinoma by the ppargamma ligand rosiglitazone impairs cancer progression 82
Vinorelbine-based chemo-radiotherapy in non-small cell lung cancer. 81
Treatment of invasive male breast cancer: a 40-year single-institution experience. 81
Radiotherapy for localized rectalcancer. 81
Normal tissues toxicities triggered by combined anti-angiogenic and radiation therapies: hurdles might be ahead. 81
Outcome After Conservative Surgery and Breast Irradiation in 5,717 Patients with Breast Cancer: Implications for Supraclavicular Nodal Irradiation. 80
Neoadjuvant treatment of soft tissue sarcoma. 79
The CXCR4/CXCL12 axis in endometrialcancer. 78
Inhibition of poly(ADP-ribose) polymerase-1 radio-sensitizes human soft tissue sarcoma cells 78
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society. 78
External beam radiotherapy in thyroid carcinoma: Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group 78
Radiotherapy timing in the treatment of limited-stage small cell lung cancer: the impact of thoracic and brain irradiation on survival. 77
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 75
PROCEDURE FOR CRANIOSPINAL AXIS RADIOTHERAPY (CSI) TECHNIQUE IN CONFORMAL (3DCRT) WITH HALFBEAM AND SINGLE JUNCTION CABINET 74
Magnetic resonance imaging in stem cell applications 73
Protective effect of leuprorelin on radiation-induced intestinal toxicity 72
RADIOSENSITIZING EFFECT OF ROSIGLITAZONE IN HEAD-NECK CARCINOMA AND PROTECTION IN RADIATION-INDUCED MUCOSITIS 71
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 70
Cyberknife stereotactic radiosurgery for the re-irradiation of brain lesions: a single-centre experience. 69
Evaluation of coumarin-tagged deferoxamine as a Zr(IV)-based PET/fluorescence dual imaging probe 68
Integrating stereotactic body radiation therapy (SBRT) and systemic treatments in oligoprogressive prostate cancer: new evidence from the literature 68
Olive phenols preserve lamin B1 expression reducing cGAS/STING/NFκB-mediated SASP in ionizing radiation-induced senescence. 67
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 66
May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk? 64
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 63
Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery 63
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 62
Totale 11.047
Categoria #
all - tutte 36.010
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.010


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.468 0 0 0 0 234 256 238 232 198 126 151 33
2020/2021973 99 77 64 110 61 84 37 74 90 130 99 48
2021/2022755 18 63 64 55 26 21 28 67 32 27 137 217
2022/20232.074 190 441 90 118 145 369 253 119 219 18 70 42
2023/2024827 37 84 124 40 50 105 39 209 14 40 57 28
2024/20253.436 200 546 348 919 1.423 0 0 0 0 0 0 0
Totale 11.865